Is the Weight-Loss Drug Market Really a Winner-Take-All Fight Between Novo Nordisk (NVO) and Eli Lilly (LLY)?

Summary

An analysis article questioning whether the weight-loss drug market is a winner-take-all competition between Novo Nordisk and Eli Lilly. No specific clinical, regulatory, or financial events are reported.